• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Accretion Pharmaceuticals Ltd.
    21 May 2025
    10-year low
    57.40
    -2.71%
    Accretion Pharmaceuticals shares list at 22% discount on NSE SME
    Business Standard
    Accretion Pharmaceuticals shares listed at 79 per share, reflecting a discount of 22 or 21.78 per cent over the issue price of 101 per share
    Copy LinkShare onShare on Share on Share on
    Accretion Pharmaceuticals Ltd. has lost -43.17% in the last 1 Year
    logo
    Emcure Pharmaceuticals Ltd.
    21 May 2025
    1339.90
    2.73%
    Emcure Pharmaceuticals Q4 Results: Date, Dividend Details, Earnings Call Schedule And More
    Emcure Pharmaceuticals Q4 Results: Date, Dividend Details, Earnings Call Schedule And More
    NDTV Profit
    The company has scheduled an earnings call with investors and analysts on May 22 at 3:30 p.m. to discuss the Q4 and FY25 results.
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd. is trading at high day volume of 159.3K.
    logo
    Torrent Pharmaceuticals Ltd.
    21 May 2025
    3514.70
    -1.47%
    Torrent Pharma Q4 Review: Motilal Oswal Maintains 'Neutral', Says Current Valuation Factors In Earnings Upside
    Torrent Pharma Q4 Review: Motilal Oswal Maintains 'Neutral', Says Current Valuation Factors In Earnings Upside
    NDTV Profit
    Motilal Oswal maintains 'Neutral' stance on Torrent Pharma, but hikes target price
    Copy LinkShare onShare on Share on Share on
    Torrent Pharmaceuticals Ltd. is trading above its 200 day SMA of 3330.1
    Torrent Pharma Q4 Results: Profit Rises 11%; Rs 5,000-Crore Fundraise On The Anvil
    NDTV Profit | 20 May 2025 2 more
    Torrent Pharma Q4 PAT up 11% on strong India biz; Aman Mehta named MD
    Business Standard | 20 May 2025
    Torrent Pharma records 15.4% growth in net profit for FY25
    Business Line | 20 May 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    21 May 2025
    1631.20
    -0.31%
    Sun Pharma Q4 Results Preview: Sales Growth Led By gRevlimid, R&D Guidance For FY26 In Focus
    Sun Pharma Q4 Results Preview: Sales Growth Led By gRevlimid, R&D Guidance For FY26 In Focus
    NDTV Profit
    As per Bloomberg estimates, Sun Pharma's consolidated revenue for the March quarter is expected to rise 12.9% year-on-year to Rs 13,254.38 crore, compared to Rs 11,813.33 crore a year ago.
    Copy LinkShare onShare on Share on Share on
    Motilal Oswal released a Buy report for Sun Pharmaceutical Industries Ltd. with a price target of 1960.0 on 23 Sep, 2025.
    Sun Pharma Q4 preview: Analysts expect 18% jump in profit; check details
    Business Standard | 20 May 2025
    logo
    Cipla Ltd.
    20 May 2025
    1517.70
    0.31%
    Aiming to enter newer categories, generate revenue of 1,500 crore: Cipla Health
    Business Line
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. has an average target of 1702.60 from 10 brokers.
    logo
    Lupin Ltd.
    20 May 2025
    1973.60
    -0.39%
    Lupin partners with Honeywell to develop eco-friendly inhalers
    Business Line
    The partnership aims to transform respiratory care for asthma and chronic obstructive pulmonary disease (COPD) patients while significantly reducing environmental impact
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading above its 100 day SMA of 1960.5
    logo
    Pfizer Ltd.
    20 May 2025
    Tariff Relief
    5222.50
    1.39%
    Pfizer Q4 net profit jumps 85% to 331 crore; revenue rises 8.3%
    Business Standard
    Pfizer's Q4 profit surged to 331 crore, aided by a 172 crore gain from land sale; board declares 165 dividend per share, including special payouts for FY25
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. average weekly volume is high.
    Pfizer share climbs 11% post healthy Q4; announces Rs 165 dividend for FY25
    Business Standard | 20 May 2025
    logo
    Eris Lifesciences Ltd.
    20 May 2025
    1593.30
    -1.94%
    Eris Lifesciences rises 4% on posting Q4 results; Check all details here
    Business Standard
    Eris Lifesciences stock advances 4 per cent as the company posts consolidated net profit for the quarter stood at 102 crore, rising 28 per cent YoY
    Copy LinkShare onShare on Share on Share on
    Eris Lifesciences Ltd. is trading above its 200 day SMA of 1508.2
    Eris Lifesciences Q4 Results Review: Motilal Oswal Maintains 'Neutral', But Hikes Target Price - Here's Why
    NDTV Profit | 20 May 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    20 May 2025
    1631.20
    -0.31%
    Sun Pharma's Checkpoint Bid Seen As A Strategic Win By Macquarie
    Sun Pharma's Checkpoint Bid Seen As A Strategic Win By Macquarie
    NDTV Profit
    The acquisition strengthens Sun Pharma's position in dermatology-oncology, according to Macquarie.
    Copy LinkShare onShare on Share on Share on
    Motilal Oswal released a Buy report for Sun Pharmaceutical Industries Ltd. with a price target of 1960.0 on 23 Sep, 2025.
    logo
    Mankind Pharma Ltd.
    20 May 2025
    2448.00
    0.34%
    Mankind Pharma Q4 Results Preview: Tariff-Related Risks, Potential Margin Pressure In Focus
    Mankind Pharma Q4 Results Preview: Tariff-Related Risks, Potential Margin Pressure In Focus
    NDTV Profit
    As per Bloomberg estimates, Mankind Pharma's consolidated revenue for the March quarter is expected to rise 26.8% year-on-year to Rs 3,095.7 crore, compared to Rs 2,441.10 crore a year ago.
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. has an average target of 2840.50 from 2 brokers.
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • DSM Fresh Foods
    • Greenleaf Envirotech
    • NSB BPO Solutions
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)